Evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters
The results showed that treatment was associated with: a reduction in hyperphagia, as reflected by an average drop of 8.5 points in the Hyperphagia Questionnaire for Clinical Trials (HQ-CT) score, a caregiver-reported assessment of hyperphagia-related behaviors a trend toward decreased body fat, by about 1.5%, and increased lean muscle, by more than 2% A global Phase 3 trial dubbed HERO (NCT06828861) is now testing ARD-101, taken twice daily for about three months, against a placebo in an estimated 90 teenagers and adults with PWS
Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges
Understandin g the 6 week plan Ozempic weight loss results requires understanding how the drug actually works
These medications often exceed $1,000 per month without insurance, and while Medicaid gets manufacturer rebates, spending has surged
Body fat distribution changes differ, with men seeing more concentrated midsection reduction and women experiencing more distributed fat loss